Fischer Medical Ventures Ltd (Fischer MV), a pioneering force in the healthcare industry, confirmed its investment and collaboration with Bio Angle Vacs Sdn Bhd (BAV), a leading Biotechnology company in Malaysia that develops, manufactures and distributes vaccines to small and large-scale farming owners worldwide; focusing on health and disease prevention for livestock and aquaculture.

BAV have to date secured a total of US$ 83 million annual sales contracts from China, Nigeria, Kenya, Chad, Uganda, Uzbekistan and Indonesia for its range of innovative, sought-after animal vaccines.

Fischer MV (formerly known as Fischer Chemic Ltd) is known for its affordable and high quality medical diagnostic and imaging technologies, by leveraging cutting-edge innovations and AI-powered software solutions in healthcare. As the first company to indigenously manufacture advanced Magnetic Resonance Imaging (MRI) systems in India, Fischer MV also owns a diverse portfolio of breakthrough diagnostic solutions and AI healthcare platform.

Founded in 2013, BAV has revolutionized the animal vaccination industry with its ground-breaking delivery methods that prioritize quality, safety, and efficacy. Its flagship innovation, the Spray Technology Vaccine (STVAC), was developed and patented by BAV’s founder, Prof. Mohd Zamri Saad, in collaboration with scientists from the Faculty of Veterinary Medicine at Universiti Putra Malaysia (UPM).

Ravindran Govindan, Executive Chairman & MD of Fischer MV, announces the collaboration with confidence: “This collaboration with BAV is our commitment in food security, starting from India with the 2nd largest sheep & goat population of about 223 million, and where food security is a growing issue. With Fischer MV’s expertise in MedTech solutions, robust resources, and strategic network, we look forward to bring BAV’s ground-breaking, cost-effective animal vaccines and products to the rest of the world to improve our food safety.”

Noor Shazreena Ishak, CEO of BAV is elated to partner Fischer MV: “In view of the growing demand for preventive healthcare in the animal world, we are committed to offer easy, cost-effective and, trustworthy solutions to relief the stress of our livestock and aquaculture and greatly improve the ROI of farmers. Through this collaboration with Fischer MV, we will have stronger science, tech and marketing support to meet the global demand for quality and affordable animal vaccines, and ultimately help reduce the burden of animal diseases worldwide.”

This partnership with BAV represents a pivotal moment for Fischer MV to advance its mission to strengthen global food security and health. Fischer MV is committed to take a major step towards ensuring world's food supply remains safe and resilient, directly contributing to better healthcare and healthier lives for people everywhere.